Search results for: Market Access
Filter search results
OHE at HTAi Rome
12 July 2017
…gave a presentation on Access to Orphan Drugs in the UK and Other European Countries. This study compares the availability and access to orphan medicinal products across the EU, fin…
Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
1 December 2017
…access across England, Scotland and Wales. The centralised procedure was created in 1995 to facilitate access to innovative medicines across the European Union. Since then the scope of authorisation via…
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
1 March 2019
…Towse, A., Segel C.S., Henshall, C., Pearson, S.D. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates. Institute for Clinical and Economic Review and the…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
OHE, in collaboration with Pfizer, hosted an educational symposium entitled “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA methodologies Appropriately Value and Enable Access?”….
How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards
24 November 2015
…and using it to support decision-making by regulators and payers is changing. Regulatory flexibilities and increasing public pressure to facilitate earlier access to medicines (e.g. through adaptive pathways or early…
Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature
9 April 2018
…available for free download. Click here to access the paper (free access ends on 7 May 2018). Cite as: Shah, K.K., Tsuchiya, A. and Wailoo, A.J., 2018. Valuing health…
How to Analyse EQ-5D Data? Methods for Analysing and Reporting EQ-5D Data: The Indispensable New Guide
8 December 2020
“Methods for Analysing and Reporting EQ-5D Data” is the first published guide on how to analyse data produced by the EQ-5D. The official launch of this new, open-access book will…
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…becomes less scarce and more easily accessible, or it can be substituted for a broader range of comparable alternatives, the value of that good decreases. A positive ‘wealth’ component (see…
Around The World in HTAs: Spain – Are We There Yet?
15 March 2023
…body that makes the final decision about market access to new health technologies at a national level. The CISNS comprises the Health Minister of Spain plus the highest hierarchy level…